找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Surgical Oncology Manual; Frances C. Wright,Jaime Escallon,Usmaan Hameed Book 20162nd edition University of Toronto General Surgery Oncolo

[復(fù)制鏈接]
樓主: 雜技演員
21#
發(fā)表于 2025-3-25 04:13:57 | 只看該作者
22#
發(fā)表于 2025-3-25 10:41:13 | 只看該作者
Jennifer Racz M.D., M.B.A., F.R.C.S.C.,Anthony M. Joshua M.B.B.S., Ph.D., F.R.A.C.P.,Joan E. Lipa MD
23#
發(fā)表于 2025-3-25 14:18:11 | 只看該作者
Trevor D. Hamilton M.D., F.R.C.S.C.,Savtaj S. Brar M.D., M.Sc., F.R.C.S.C,Nicole J. Look Hong M.D.,
24#
發(fā)表于 2025-3-25 17:31:45 | 只看該作者
25#
發(fā)表于 2025-3-25 21:13:46 | 只看該作者
Tumours of the Adrenal Gland,surgical resection and consideration of adjuvant mitotane. Pheochromocytomas may be benign or malignant. Essential components of perioperative management include alpha blockage followed by beta blockade.
26#
發(fā)表于 2025-3-26 04:06:32 | 只看該作者
Gastric Adenocarcinoma,iotherapy plays an important role in both the adjuvant and palliative setting. The complex multidisciplinary management of gastric cancer remains in evolution as we strive to further improve outcomes in this patient population.
27#
發(fā)表于 2025-3-26 07:38:17 | 只看該作者
Melanoma,esection, intralesional agents, topical therapy, and limb infusion/perfusion. Systemic therapies for distant metastatic melanoma have dramatically improved in the past decade with the use of targeted BRAF and MEK inhibitors, immunotherapy with anti-CTLA4 agents and PD-1 inhibitors.
28#
發(fā)表于 2025-3-26 10:51:44 | 只看該作者
Adenocarcinoma of the Pancreas,Treatment of pancreatic cancer depends on the stage of disease. Surgery is the only curative treatment for localized disease. Completeness of resection (R0) is prognostically important. Adjuvant chemotherapy is currently recommended as standard of care.
29#
發(fā)表于 2025-3-26 15:33:06 | 只看該作者
Breast Cancer,g of the complete spectrum of breast pathology, both malignant and premalignant. Within this chapter, an overview of this continuum is presented: from high-risk pathologies, through pre-invasive disease, to invasive disease and its subtypes. Relevant trials are presented, as are options and considerations for breast reconstruction.
30#
發(fā)表于 2025-3-26 20:15:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 17:39
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
衡山县| 京山县| 新乐市| 临城县| 茂名市| 彭阳县| 渑池县| 化德县| 普格县| 通许县| 神池县| 清镇市| 张家港市| 万安县| 旬阳县| 泰宁县| 松桃| 乐业县| 敦化市| 嘉义市| 南澳县| 长子县| 西充县| 齐齐哈尔市| 云浮市| 海城市| 三门峡市| 德保县| 贵南县| 沧州市| 抚远县| 广宁县| 昌邑市| 平顶山市| 华阴市| 睢宁县| 河东区| 宣化县| 抚宁县| 鄂伦春自治旗| 莱州市|